Hub of biotherapeutic intelligence
Ingrid Brands MD PhD
Chief Innovation and Strategy Officer
Ingrid Brands is the Chief Innovation and Strategy Officer of ImmunoPrecise Antibodies, with over two decades in management and senior research roles. She has made significant contributions to the field of medicine and neurorehabilitation.
Throughout her career, Dr. Brands has pioneered innovative approaches in neuropsychological rehabilitation, enhancing the care provided to patients with acquired brain injuries. She has held respected research positions at esteemed institutions such as Libra Revalidatie & Audiologie and the Department of Rehabilitation at Erasmus University.
Dr. Brands holds a Ph.D. in neurorehabilitation from the University of Maastricht and graduated with distinction from the University of Leuven, specializing in Physical Medicine and Rehabilitation (PM&R). Her commitment to advancing the field is evident in her academic achievements and active involvement in professional committees.
Under Dr. Brands' leadership, IPA and its subsidiary BioStrand continue to evolve, utilizing cutting-edge research and technology to drive advancements in genetic research. Her dedication to innovation and patient care serves as the driving force behind IPA's achievements.